The global myelodysplastic syndrome drugs market size was estimated at USD 2.88 billion in 2023 and is projected to reach USD 5.28 billion by 2030, growing at a CAGR of 9.1% from…
The global myelodysplastic syndrome drugs market size was estimated at USD 2.88 billion in 2023 and is projected to reach USD 5.28 billion by 2030, growing at a CAGR of 9.1% from…